{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:27:45Z","timestamp":1789244865772,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-05427-2","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T09:03:35Z","timestamp":1737018215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic factors and survival outcomes in patients with salivary duct carcinoma: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Fei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqiao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenghao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5556-0429","authenticated-orcid":false,"given":"Jingqiu","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6089-2202","authenticated-orcid":false,"given":"Haizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"5","key":"5427_CR1","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hed.23350","volume":"36","author":"V Jayaprakash","year":"2014","unstructured":"Jayaprakash V, Merzianu M, Warren GW, et al. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck. 2014;36(5):694\u2013701.","journal-title":"Head Neck"},{"issue":"9","key":"5427_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/jop.12426","volume":"45","author":"H Breinholt","year":"2016","unstructured":"Breinholt H, Elhakim MT, Godballe C, et al. Salivary duct carcinoma: a Danish national study. J Oral Pathol Med. 2016;45(9):664\u201371.","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"5427_CR3","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1245\/s10434-015-5082-2","volume":"23","author":"K Otsuka","year":"2016","unstructured":"Otsuka K, Imanishi Y, Tada Y, et al. Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients. Ann Surg Oncol. 2016;23(6):2038\u201345.","journal-title":"Ann Surg Oncol"},{"key":"5427_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.oraloncology.2017.09.008","volume":"74","author":"NC Schmitt","year":"2017","unstructured":"Schmitt NC, Kang H, Sharma A. Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy. Oral Oncol. 2017;74:40\u20138.","journal-title":"Oral Oncol"},{"issue":"11","key":"5427_CR5","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/j.oraloncology.2014.08.010","volume":"50","author":"JL Roh","year":"2014","unstructured":"Roh JL, Lee JI, Choi SH, et al. Prognostic factors and oncologic outcomes of 56 salivary duct carcinoma patients in a single institution: high rate of systemic failure warrants targeted therapy. Oral Oncol. 2014;50(11):e64\u20136.","journal-title":"Oral Oncol"},{"issue":"6","key":"5427_CR6","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00405-020-06247-6","volume":"278","author":"T Nakashima","year":"2021","unstructured":"Nakashima T, Yasumatsu R, Toh S, et al. Prognostic value of extranodal extension in patients with salivary duct carcinoma. Eur Arch Otorhinolaryngol. 2021;278(6):1965\u201372.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"8","key":"5427_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jcms.2014.08.001","volume":"42","author":"S Shi","year":"2014","unstructured":"Shi S, Fang Q, Liu F, et al. Prognostic factors and survival rates for parotid duct carcinoma patients. J Craniomaxillofac Surg. 2014;42(8):1929\u201331.","journal-title":"J Craniomaxillofac Surg"},{"issue":"11","key":"5427_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/hed.24484","volume":"38","author":"MJ Mifsud","year":"2016","unstructured":"Mifsud MJ, Tanvetyanon T, McCaffrey JC, et al. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas. Head Neck. 2016;38(11):1628\u201333.","journal-title":"Head Neck"},{"key":"5427_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1758-3284-4-19","volume":"4","author":"A Lagha","year":"2012","unstructured":"Lagha A, Chraiet N, Ayadi M, et al. Systemic therapy in the management of metastatic or advanced salivary gland cancers. Head Neck Oncol. 2012;4:19.","journal-title":"Head Neck Oncol"},{"issue":"4","key":"5427_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ijc.31353","volume":"143","author":"E Boon","year":"2018","unstructured":"Boon E, Bel M, van Boxtel W, et al. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands. Int J Cancer. 2018;143(4):758\u201366.","journal-title":"Int J Cancer"},{"issue":"5","key":"5427_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","volume":"39","author":"L Williams","year":"2015","unstructured":"Williams L, Thompson LD, Seethala RR, et al. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol. 2015;39(5):705\u201313.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"5427_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1158\/1078-0432.CCR-12-1842","volume":"19","author":"V Nardi","year":"2013","unstructured":"Nardi V, Sadow PM, Juric D, et al. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. Clin Cancer Res. 2013;19(2):480\u201390.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"5427_CR13","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3109\/00016489.2016.1170876","volume":"136","author":"K Nakano","year":"2016","unstructured":"Nakano K, Sato Y, Sasaki T, et al. Combination chemotherapy of carboplatin and paclitaxel for advanced\/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses. Acta Otolaryngol. 2016;136(9):948\u201351.","journal-title":"Acta Otolaryngol"},{"issue":"4","key":"5427_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdx771","volume":"29","author":"C Fushimi","year":"2018","unstructured":"Fushimi C, Tada Y, Takahashi H, et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol. 2018;29(4):979\u201384.","journal-title":"Ann Oncol"},{"issue":"2","key":"5427_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1200\/JCO.18.00545","volume":"37","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Tada Y, Saotome T, et al. Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma. J Clin Oncol. 2019;37(2):125\u201334.","journal-title":"J Clin Oncol"},{"issue":"12","key":"5427_CR16","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/ijc.27441","volume":"130","author":"D Buergy","year":"2012","unstructured":"Buergy D, Wenz F, Groden C, et al. Tumor-platelet interaction in solid tumors. Int J Cancer. 2012;130(12):2747\u201360.","journal-title":"Int J Cancer"},{"key":"5427_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pharmthera.2015.11.005","volume":"157","author":"B Tesfamariam","year":"2016","unstructured":"Tesfamariam B. Involvement of platelets in tumor cell metastasis. Pharmacol Ther. 2016;157:112\u20139.","journal-title":"Pharmacol Ther"},{"issue":"11","key":"5427_CR18","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1007\/s00520-015-2720-y","volume":"23","author":"S Mercadante","year":"2015","unstructured":"Mercadante S, Aielli F, Adile C, et al. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer. 2015;23(11):3249\u201355.","journal-title":"Support Care Cancer"},{"issue":"9","key":"5427_CR19","doi-asserted-by":"publisher","first-page":"15632","DOI":"10.18632\/oncotarget.14921","volume":"8","author":"L Gao","year":"2017","unstructured":"Gao L, Zhang H, Zhang B, et al. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer. Oncotarget. 2017;8(9):15632\u201341.","journal-title":"Oncotarget"},{"issue":"6","key":"5427_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.anl.2015.04.005","volume":"42","author":"MW Han","year":"2015","unstructured":"Han MW, Roh JL, Choi SH, et al. Prognostic factors and outcome analysis of salivary duct carcinoma. Auris Nasus Larynx. 2015;42(6):472\u20137.","journal-title":"Auris Nasus Larynx"},{"key":"5427_CR21","unstructured":"Schmitt NC, Bishop JA, Tian L, et al. Salivary duct carcinoma in the parotid vs. submandibular gland: A survival analysis from the National Cancer Database. Oral Oncol. 2021;117:105314."},{"issue":"11","key":"5427_CR22","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jamaoto.2016.2168","volume":"142","author":"A Amini","year":"2016","unstructured":"Amini A, Waxweiler TV, Brower JV, et al. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base. JAMA Otolaryngol Head Neck Surg. 2016;142(11):1100\u201310.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"4","key":"5427_CR23","first-page":"1203","volume":"43","author":"BJ Gebhardt","year":"2021","unstructured":"Gebhardt BJ, Ohr JP, Ferris RL, et al. Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Salivary Gland Cancers. Head Neck. 2021;43(4):1203\u201312.","journal-title":"Head Neck"},{"key":"5427_CR24","doi-asserted-by":"crossref","unstructured":"Cohen RB, Delord JP, Doi T, et al. Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study. Am J Clin Oncol. 2018;41(11):1083\u20131088.","DOI":"10.1097\/COC.0000000000000429"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-05427-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T09:03:40Z","timestamp":1737018220000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-025-05427-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5427"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-05427-2","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Research Ethics Committee of the Chinese PLA General Hospital (S2019-016\u201302). Informed consent was obtained from all patients.All methods were conducted in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}